Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty

EuroIntervention 2014;10:312-319 published online ahead of print November 2013. DOI: 10.4244/EIJV10I3A54

Annapoorna Kini
Annapoorna Kini1, MD; Jennifer Yu1,2, MBBS; Mauricio G. Cohen3, MD; Roxana Mehran1, MD; Usman Baber1, MD; Samantha Sartori1, PhD; Georgios J. Vlachojannis1, MD; Jason C. Kovacic1, MD; Robert Pyo1, MD; Brian O’Neill3, MD; Vikas Singh3, MD; Evan Jacobs3, MD; Shyam Poludasu1, MD; Pedro Moreno1, MD; Michael C. Kim1, MD; Prakash Krishnan1, MD; Samin K. Sharma1, MD; George D. Dangas1*, MD, PhD
1. Mount Sinai Medical Center, New York, NY, USA; 2. Prince of Wales Clinical School, University of New South Wales, NSW, Australia; 3. University of Miami Miller School of Medicine, Miami, FL, USA

Aims: We sought to assess if bivalirudin use during balloon aortic valvuloplasty (BAV) would affect clinical outcomes compared with heparin.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

anticoagulantsballoon aortic valvuloplastybivalirudinbleeding
Read next article
Functional coronary stenosis severity assessed from the mean pressure gradient-velocity relationship obtained by contrast medium-induced submaximal hyperaemia

Latest news